A study published in Cell Press reveals the significant role of gamma-delta T cells in treatment outcomes for 33 cancer types ...

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

Human innate immune cells that “remember” previous stimulation could provide new insights into chronic inflammatory diseases.

ALLO1, has shown promising results in treating heavily pretreated patients with relapsed/refractory multiple myeloma.

A new CAR T-cell therapy, durcabtagene autoleucel, showed promising results in treating relapsed/refractory multiple myeloma ...

In a follow-up study, researchers compared cancer immunotherapy in mice, using either single or double immune responses. And ...

A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic ...

An oral session Friday at the International Myeloma Society 21st Annual Meeting & Exposition offered updates for the TRIMM-2 ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells. First cohort at 150 million CAR+T cells already successfully completed ...

Widespread cell service outages persist days after Hurricane Helene made landfall. Could cell phone providers be doing more?